Molecular mechanisms of autism: a possible role for Ca2+ signaling

Current Opinion in Neurobiology

Volumn 17, Issue 1, 2007, Pages 112-119

  Krey, Jocelyn F ^a   Dolmetsch, Ricardo E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; NEUROTRANSMITTER RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

AUTISM; CALCIUM SIGNALING; DENDRITIC CELL; DEVELOPMENTAL DISORDER; EMOTIONAL DISORDER; ENVIRONMENTAL FACTOR; HUMAN; LANGUAGE DISABILITY; MOLECULAR BIOLOGY; NERVE CELL EXCITABILITY; NERVE CELL GROWTH; NEUROTRANSMISSION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOCIAL ASPECT; STEREOTYPY; SYNAPSE;

AUTISTIC DISORDER; BRAIN; CALCIUM SIGNALING; CELL DIFFERENTIATION; ENVIRONMENT; HUMANS; ION CHANNELS; RECEPTORS, NEUROTRANSMITTER; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 33846878716     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2007.01.010     Document Type: Review

References (81)

1. Fombonne E. The prevalence of autism. J Am Med Assoc 289 (2003) 87-89
2. Persico A.M., and Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29 (2006) 349-358
3. Gupta A.R., and State M.W. Recent advances in the genetics of autism. Biol Psychiatry (2006). http://www.sciencedirect.com/science/journal/00063223 10.1016/j.biopsych.2006.06.020
4. Moody W.J., and Bosma M.M. Ion channel development, spontaneous activity, and activity-dependent development in nerve and muscle cells. Physiol Rev 85 (2005) 883-941
5. 2+ spikes specify transmitter choice. Trends Neurosci 27 (2004) 415-421
6. 2+ fluctuations. J Neurobiol 37 (1998) 110-130
7. Represa A., and Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci 28 (2005) 278-283
8. Aamodt S.M., and Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv Neurol 79 (1999) 133-144
9. Cline H.T. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 11 (2001) 118-126
10. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., Schultz R.T., Crawley J., and Young L.J. The developmental neurobiology of autism spectrum disorder. J Neurosci 26 (2006) 6897-6906
11. Courchesne E., Redcay E., Morgan J.T., and Kennedy D.P. Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Dev Psychopathol 17 (2005) 577-597
12. 2+ channels and autism.
13. 2+ channels.
14. V3.2) in six of 461 individuals with ASD. These mutations altered different functional properties of the channel, many leading to lower current densities.
15. Splawski I., Timothy K.W., Decher N., Kumar P., Sachse F.B., Beggs A.H., Sanguinetti M.C., and Keating M.T. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA 102 (2005) 8089-8096
16. Catterall W.A., Perez-Reyes E., Snutch T.P., and Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57 (2005) 411-425
17. Dolmetsch R.E., Pajvani U., Fife K., Spotts J.M., and Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294 (2001) 333-339
18. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J., Takasu M.A., Tao X., and Greenberg M.E. Calcium regulation of neuronal gene expression. Proc Natl Acad Sci USA 98 (2001) 11024-11031
19. Hope C.I., Sharp D.M., Hemara-Wahanui A., Sissingh J.I., Lundon P., Mitchell E.A., Maw M.A., and Clover G.M. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2. Clin Experiment Ophthalmol 33 (2005) 129-136
20. Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83 (2003) 117-161
21. Weiss L.A., Escayg A., Kearney J.A., Trudeau M., MacDonald B.T., Mori M., Reichert J., Buxbaum J.D., and Meisler M.H. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry 8 (2003) 186-194
22. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., and Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (2003) 885-889
23. 2+-dependent BDNF transcription and repress dendritic growth. These results suggest a role for MeCP2 in activity-dependent gene expression and provide a possible reason for the neural-specific pathology of Rett syndrome.
24. 2+ sensitivity of sodium channels. J Biol Chem 279 (2004) 45004-45012
25. Glaaser I.W., Bankston J.R., Liu H., Tateyama M., and Kass R.S. A carboxyl-terminal hydrophobic interface is critical to sodium channel function. Relevance to inherited disorders. J Biol Chem 281 (2006) 24015-24023
26. Ca channel. This study was the first to propose KNCMA1 as a possible candidate gene for ASD, but further work is needed to test its involvement.
27. + channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci 21 (2001) 9585-9597
28. Barnby G., Abbott A., Sykes N., Morris A., Weeks D.E., Mott R., Lamb J., Bailey A.J., and Monaco A.P. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am J Hum Genet 76 (2005) 950-966
29. Jamain S., Betancur C., Quach H., Philippe A., Fellous M., Giros B., Gillberg C., Leboyer M., and Bourgeron T. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7 (2002) 302-310
30. Serajee F.J., Zhong H., Nabi R., and Huq A.H. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 40 (2003) e42
31. A receptor subunit genes in autistic disorder. J Neurogenet 15 (2001) 245-259
32. Nurmi E.L., Bradford Y., Chen Y., Hall J., Arnone B., Gardiner M.B., Hutcheson H.B., Gilbert J.R., Pericak-Vance M.A., Copeland-Yates S.A., et al. Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism families. Genomics 77 (2001) 105-113
33. Dykens E.M., Sutcliffe J.S., and Levitt P. Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Ment Retard Dev Disabil Res Rev 10 (2004) 284-291
34. Collins A.L., Ma D., Whitehead P.L., Martin E.R., Wright H.H., Abramson R.K., Hussman J.P., Haines J.L., Cuccaro M.L., Gilbert J.R., et al. Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics 7 (2006) 167-174
35. Ma D.Q., Whitehead P.L., Menold M.M., Martin E.R., Ashley-Koch A.E., Mei H., Ritchie M.D., Delong G.R., Abramson R.K., Wright H.H., et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77 (2005) 377-388
36. Dan B., and Boyd S.G. Angelman syndrome reviewed from a neurophysiological perspective. The UBE3A-GABRB3 hypothesis. Neuropediatrics 34 (2003) 169-176
37. DeLorey T.M. GABRB3 gene deficient mice: a potential model of autism spectrum disorder. Int Rev Neurobiol 71 (2005) 359-382
38. Friocourt G., Poirier K., Rakic S., Parnavelas J.G., and Chelly J. The role of ARX in cortical development. Eur J Neurosci 23 (2006) 869-876
39. Turner G., Partington M., Kerr B., Mangelsdorf M., and Gecz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. Am J Med Genet 112 (2002) 405-411
40. Stromme P., Mangelsdorf M.E., Shaw M.A., Lower K.M., Lewis S.M., Bruyere H., Lutcherath V., Gedeon A.K., Wallace R.H., Scheffer I.E., et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 30 (2002) 441-445
41. Hamilton S.P., Woo J.M., Carlson E.J., Ghanem N., Ekker M., and Rubenstein J.L. Analysis of four DLX homeobox genes in autistic probands. BMC Genet 6 (2005) 52
42. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., et al. From the cover: a genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 103 (2006) 16834-16839. This study describes a strong association between autism and a variant of the gene encoding MET, a tyrosine kinase receptor known to regulate the migration of inhibitory neurons.
43. Birchmeier C., and Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8 (1998) 404-410
44. Powell E.M., Mars W.M., and Levitt P. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 30 (2001) 79-89
45. Marin O., and Rubenstein J.L. A long, remarkable journey: tangential migration in the telencephalon. Nat Rev Neurosci 2 (2001) 780-790
46. Rubenstein J.L., and Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2 (2003) 255-267
47. Hussman J.P. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 31 (2001) 247-248
48. Leinekugel X., Khalilov I., McLean H., Caillard O., Gaiarsa J.L., Ben-Ari Y., and Khazipov R. GABA is the principal fast-acting excitatory transmitter in the neonatal brain. Adv Neurol 79 (1999) 189-201
49. Voigt T., Opitz T., and de Lima A.D. Synchronous oscillatory activity in immature cortical network is driven by GABAergic preplate neurons. J Neurosci 21 (2001) 8895-8905
50. Garaschuk O., Linn J., Eilers J., and Konnerth A. Large-scale oscillatory calcium waves in the immature cortex. Nat Neurosci 3 (2000) 452-459
51. Fukuda T., Itoh M., Ichikawa T., Washiyama K., and Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64 (2005) 537-544
52. Kishi N., and Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27 (2004) 306-321
53. Dijkhuizen P.A., and Ghosh A. BDNF regulates primary dendrite formation in cortical neurons via the PI3-kinase and MAP kinase signaling pathways. J Neurobiol 62 (2005) 278-288
54. Jaworski J., Spangler S., Seeburg D.P., Hoogenraad C.C., and Sheng M. Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25 (2005) 11300-11312
55. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., Miles J.H., Wang C.H., Stratton R., Pilarski R., et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42 (2005) 318-321
56. Goffin A., Hoefsloot L.H., Bosgoed E., Swillen A., and Fryns J.P. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105 (2001) 521-524
57. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., Li Y., Baker S.J., and Parada L.F. Pten regulates neuronal arborization and social interaction in mice. Neuron 50 (2006) 377-388. In this study, the authors generated conditional Pten mutant mice to determine the role of the PI3K-PTEN-AKT pathway in mature neurons. They found that conditional loss of PTEN in selected brain regions led to changes in dendritic and axonal growth and synapse number. These mice also developed macrocephaly and behavioral abnormalities that are similar to certain features of ASD.
58. Inoki K., Li Y., Zhu T., Wu J., and Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4 (2002) 648-657
59. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., and Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10 (2002) 151-162
60. Potter C.J., Pedraza L.G., and Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4 (2002) 658-665
61. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) e472-e486
62. Tavazoie S.F., Alvarez V.A., Ridenour D.A., Kwiatkowski D.J., and Sabatini B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8 (2005) 1727-1734. This study defines a role for the TSC pathway in regulating the morphology and synaptic properties of differentiated pyramidal neurons. The authors found that loss of TSC1 or TSC2 leads to increased soma size, decreased dendritic spine density and changes in synaptic strength. These results suggest that defects in dendritic morphology and synaptic function contribute to the neurological symptoms of tuberous sclerosis, a disorder that often presents with autism.
63. Wassink T.H., Piven J., Vieland V.J., Huang J., Swiderski R.E., Pietila J., Braun T., Beck G., Folstein S.E., Haines J.L., et al. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105 (2001) 406-413
64. Wayman G.A., Impey S., Marks D., Saneyoshi T., Grant W.F., Derkach V., and Soderling T.R. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 50 (2006) 897-909. This study provides a careful dissection of the signaling cascades that lead to the activation of CREB and to the transcription of Wnt2 in cortical neurons.
65. Lijam N., Paylor R., McDonald M.P., Crawley J.N., Deng C.X., Herrup K., Stevens K.E., Maccaferri G., McBain C.J., Sussman D.J., et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90 (1997) 895-905
66. Lise M.F., and El-Husseini A. The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 63 (2006) 1833-1849
67. Chih B., Engelman H., and Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 307 (2005) 1324-1328
68. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74 (2004) 552-557
69. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34 (2003) 27-29
70. Chih B., Afridi S.K., Clark L., and Scheiffele P. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 13 (2004) 1471-1477
71. 2+ binding in cell surface associations. Protein Sci 9 (2000) 180-185
72. Nelson K.B., and Bauman M.L. Thimerosal and autism?. Pediatrics 111 (2003) 674-679
73. Hviid A., Stellfeld M., Wohlfahrt J., and Melbye M. Association between thimerosal-containing vaccine and autism. J Am Med Assoc 290 (2003) 1763-1766
74. Limke T.L., Heidemann S.R., and Atchison W.D. Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning?. Neurotoxicology 25 (2004) 741-760
75. Elferink J.G. Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function-modulating agent. Gen Pharmacol 33 (1999) 1-6
76. Stromland K., Nordin V., Miller M., Akerstrom B., and Gillberg C. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36 (1994) 351-356
77. Christianson A.L., Chesler N., and Kromberg J.G. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 36 (1994) 361-369
78. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. Int J Dev Neurosci 23 (2005) 189-199
79. Schneider T., and Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89. This study describes a promising new animal model of autism that recapitulates some of the effects seen in the babies of mothers given valproic acid during pregnancy.
80. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., and Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr Res 52 (2002) 576-579
81. Ingram J.L., Peckham S.M., Tisdale B., and Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22 (2000) 319-324